Toxoplasmosis, Cerebral: Clinical Trials

13 trials for Toxoplasmosis, Cerebral, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 1 recruiting, 1 unknown. 5 Not applicable, 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 5
Phase 23Completed 2, Unknown 1
Phase 12Completed 2

Follow Toxoplasmosis, Cerebral: new trials by email Literature Review of Toxoplasmosis, Cerebral trials Research Report on Toxoplasmosis, Cerebral

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital
Cerebral Toxoplasmosis
RecruitingUniversity Hospital, Strasbourg, France302025-02-022025-12-23
Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)
Toxoplasmosis, Cerebral, Toxoplasmosis
CompletedCentre Hospitalier de Saint-Denis532024-07-012025-06-29
Dexamethasone for Cerebral Toxoplasmosis
Dexamethasone, Placebo - Toxoplasmosis, Cerebral
Phase 2UnknownUniversitas Padjadjaran1382021-04-162024-07-03
Driving Reduced AIDS-associated Meningo-encephalitis Mortality
DREAMM - AIDS-Related Opportunistic Infections, Meningo-encephalitis
Not applicableCompletedSt George's, University of London4952016-04-232022-05-04
Cerebral Toxoplasmosis and AIDS
Toxoplasma PCR assay - Cerebral Toxoplasmosis, AIDS
CompletedUniversity Hospital, Limoges462009-06-012019-07-05
Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
Sulfadiazine, Clarithromycin, Atovaquone - Toxoplasmosis, Cerebral, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1002021-10-28
A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine
Atovaquone - Toxoplasmosis, Cerebral, HIV Infections
Not applicableCompletedGlaxo Wellcome2005-06-24
A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients
Pyrimethamine, Leucovorin calcium, Zidovudine - Toxoplasmosis, Cerebral, HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)262021-11-04
A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
Pyrimethamine, Leucovorin calcium, Clindamycin - Toxoplasmosis, Cerebral, HIV Infections
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)302012-05-18
A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
Azithromycin, Pyrimethamine, Leucovorin calcium - Toxoplasmosis, Cerebral, HIV Infections
Phase 1CompletedPfizer452008-08-26
Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
Pyrimethamine, Leucovorin calcium - Toxoplasmosis, Cerebral, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1502021-11-02
Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse
Pyrimethamine, Clindamycin - Toxoplasmosis, Cerebral, HIV Infections
Not applicableCompletedPalo Alto Medical Foundation2005-06-24
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
Pyrimethamine - Toxoplasmosis, Cerebral, HIV Infections
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)6002012-10-29

Narrower conditions

HIV Infections (9)  ·  Acquired Immunodeficiency Syndrome (8)  ·  Toxoplasmosis (8)  ·  Encephalitis (7)  ·  AIDS-Related Opportunistic Infections (5)  ·  AIDS-Related Complex (1)  ·  Brain Diseases (1)  ·  Central Nervous System Infections (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Meningitis (1)  ·  Meningitis, Bacterial (1)  ·  Meningitis, Cryptococcal (1)  ·  Tuberculosis, Meningeal (1)

Broader conditions

Abscess (13)  ·  Brain Abscess (13)  ·  Central Nervous System Diseases (13)  ·  Central Nervous System Parasitic Infections (13)  ·  Central Nervous System Protozoal Infections (13)  ·  Coccidiosis (13)  ·  Infections (13)  ·  Nervous System Diseases (13)  ·  Parasitic Diseases (13)  ·  Protozoan Infections (13)  ·  Suppuration (13)  ·  Brain Diseases (12)  ·  Central Nervous System Infections (12)  ·  Immune System Diseases (12)  ·  Blood-Borne Infections (11)

Interventions

Pyrimethamine (7)  ·  Leucovorin (5)  ·  Atovaquone (2)  ·  Clindamycin (2)  ·  Azithromycin (1)  ·  Clarithromycin (1)  ·  Dexamethasone (1)  ·  Sulfadiazine (1)  ·  Zidovudine (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  Centre Hospitalier de Saint-Denis (1)  ·  Glaxo Wellcome (1)  ·  Palo Alto Medical Foundation (1)  ·  Pfizer (1)  ·  St George's, University of London (1)  ·  Universitas Padjadjaran (1)  ·  University Hospital, Limoges (1)  ·  University Hospital, Strasbourg, France (1)

Countries

United States (8)  ·  France (3)  ·  Cameroon (1)  ·  Canada (1)  ·  Indonesia (1)  ·  Malawi (1)  ·  Tanzania (1)

Top investigators

Luft B (3)  ·  Angela Loyse, MD (1)  ·  B Luft (1)  ·  BJ Luft (1)  ·  Besch CL (1)  ·  Chirgwin K (1)  ·  JL Vilde (1)  ·  Jacobson M (1)  ·  Remington J (1)  ·  Remington JS (1)  ·  Sofiati Dian, M.D., PhD (1)

Results publications

PMID 27355620, PMID 37802567